United States authorize the marketing of IQOS heated tobacco

The US Food and Drug Administration (FDA) has confirmed that IQOS, the Philip Morris International electric heating tobacco system, was appropriate to protect public health.

After a full badessment of pre-market demand for tobacco products (PMTA), submitted to the Agency in 2017, the FDA has decided to allow its sale in the United States. UU

Unlike regular cigarettes, the IQOS system heats up but does not burn tobacco, making it the first electrically powered product to be sold in this country.

André Calantzopoulos, executive director of Philip Morris International, announced the decision to approve the sale of IQOS in the United States. UU This is a milestone for adult American smokers, who add up to $ 40 million because this option defines this option as a "smoke-free alternative".

He added that the FDA's order establishes clear marketing guidelines, including requirements that maximize the opportunities for users to change their cigarette consumption while minimizing inappropriate use.

IQOS has been present in Guatemala since August 2017 and launched its new IQOS 3 and IQOS 3 MULTI versions in November 2018, reinforcing its goal to innovate and evolve, as soon as possible, towards a smoke-free future. in our country.

El Confidencial reported that the Food and Drug Administration (FDA) guarantees that the guarantee to sell this product does not mean that it is healthy and that it will be subject to the same restrictions as conventional products.